Equity · Healthcare
NNVC
NanoViricides, Inc. · NYSE American
The line runs $1.43 on 8 June through $1.76 on 17 July, on a scale from $1.2 to $1.8. Days the market did not trade hold the previous close, flat.
The chart above plots the price of NNVC over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 28 sessions over that window: $1.43 on 8 June 2026 through $1.76 on 17 July 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 6, 2026
Filings 4 sets
NNVC reported financials
NNVC reported revenue of $0 for the fiscal year ended 30 Jun 2025. Net income over the same period was −$9.5M.
Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026
NNVC earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
NNVC institutional holders
1 of the 45 institutional funds we track reported a NNVC position for the quarter ended 30 Jun 2026 — a combined $177K; the latest of those filings landed 13 Aug 2026.
Source: SEC EDGAR 13F filings
NNVC fails-to-deliver
On 11 Aug 2026, 905 shares of NNVC failed to deliver (about $1K).
Source: SEC fails-to-deliver (CNS) data